Facebook 20cover 20  202019 20 1
Untitled 20design 20 2

Strados Labs

For clinicians seeking critical respiratory data, Strados non-invasive smart sensors enable remote monitoring and management over the entire episode of care.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Philadelphia, PA, US
  • Currency USD
  • Founded June 2016
  • Employees 6
  • Incorporation Type C-corp
  • Website stradoslabs.com

Company Summary

Strados is a patent pending non-invasive respiratory monitor and connected platform that optimizes respiratory health management. Strados provides clinicians with insights into changes in lung health performance in real-time that enables better remote monitoring to reduce risk of pulmonary compromise and costly readmissions throughout the entire episode of care.


  • Untitled
    CEO & Founder

    Several years experience in healthcare financial and strategic advisory working with Big Pharma and leading health institutions on projects ranging from physician compensation, value-based payment models, purchase price accounting, due diligence, and strategic forecasting. Mr. Delmonico received an MBA in Healthcare at Temple University where he also started Strados Labs after attending a healthcare hackathon at Jefferson University Health System

  • 7ddc1440 a52b 41f1 95c9 4f4fa9943549

    Mr. Powers was CIO of CardioMEMS. Under his leadership at CardioMEMS, Richard and his team designed and developed a secure, cloud-based, remote chronic disease management IoT platform powering the world’s first FDA-approved implantable wireless blood pressure sensor for patients with heart failure that showed a 50% hospitalization reduction rate and was acquired for $455M

  • Default avatar
    Mitchell Glass, MD
    Chief Medical Officer

    Dr. Mitchell Glass is a 30-year veteran of the pharmaceutical industry. His experience is broad, ranging from senior positions in top ten pharmaceutical companies to investment in and management of start-ups and biotechs. He has successful exits and IPOs including AtheroGenix (NASDAQ, 2004) and dozens of successful trials.

  • C6879661 58a1 4d4c af0a e2b82b38dfe0
    Chief Technology Officer

    25+ years experience in developing and commercializing medical device products. He has successfully led teams focused on integrating hardware sensor data with a remote patient monitoring platform for companies like CardioMEMs (acquired by St. Jude Medical of $455M in 2013) and Sarvint Technologies.

Previous Investors